| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.29M | 50.2% | $1.02 | +$1.32M |
| Sells | 1 | -1.28M | 49.8% | $0.66 | -$846K |
| Net | 0 | +8.85K | 0.3% | +$470K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| SHV Management Services, LLC | 10%+ Owner | $3.4M | Jun 13, 2022 | ||
| Kevin M. Lalande | Director, 10%+ Owner | $2.49M | Sep 27, 2024 | ||
| Biotech Target N V | 10%+ Owner | $413K | +$470K | Nov 14, 2024 | |
| Sean McLennan | Chief Financial Officer (interim) and Treasurer | $14.1K | Jun 16, 2022 | ||
| Eric E. Poma | Chief Executive Officer and Chief Scientific Officer, Director | Jan 23, 2024 | |||
| Roger J. Waltzman | Chief Medical Officer | Feb 15, 2023 | |||
| Jonathan Lanfear | Director | Oct 27, 2023 | |||
| Harold E. Selick | Director | Sep 27, 2024 | |||
| Jason S. Kim | Chief Financial Officer | Jan 23, 2024 | |||
| Gabriela Gruia | Director | Sep 27, 2024 | |||
| Dave Hoffmann | Director | Sep 27, 2024 | |||
| Maurizio Voi | Chief Medical Officer | Jan 23, 2024 | |||
| Corazon (. D. Sanders | Director | Sep 27, 2024 | |||
| David Hirsch | Director | Jun 3, 2022 | |||
| Scott D. Morenstein | Director | Jun 3, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|